PACTR202407805328722Not yet recruitingPhase 4
Effect of hyoscine N-Butyl bromide on progress of labour and pregnancy outcome; A randomized control trial
Rahmat Adamu0 sites128 target enrollmentStarted: February 8, 2024Last updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 128
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 19 Year(s) to 44 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •1. Pregnant women with term pregnancy gravida 1 to gravida 5
- •2.Those that consented to partake in the study
- •3.Aged 18 and above
- •4.Women in active phase of labour
- •5.Women with no contraindication to drug use
- •6.Singleton foetus at term
- •7.Cephalic presentation
Exclusion Criteria
- •1. Women with contraindication to vaginal delivery
- •2.Women with any present or past obstetric emergency/complication
- •3.Intrauterine fetal Death (IUFD)
- •4.Fully dilated
- •5.Suspected fetal distress
Investigators
Similar Trials
Completed
Phase 3
The effect of Hyoscine -suppository on laborCondition 1: Labor pain. Condition 2: Labor process.spontaneus vertex deliveryIRCT138804282204N1Research vice chancellor of Ahwaz jondishapour university of medical sciences130
Not yet recruiting
Not Applicable
Effect of Hyoscine N Butyl Bromide (HNBB)on duration and pain relief in labourCTRI/2020/12/030069Dr Arularasan J
Completed
Phase 3
Comparison of the effect of Hyoscine N-Butylbromide on the propofol injection paiIRCT20190109042309N2Sabzevar University of Medical Sciences80
Completed
Phase 2
The effect of Hyoscine butyl bromide on the duration of the first stage of labour in nulliparous women: A randomised controlled trial in Wuse District Hospital, Abuja.PACTR202402717378543DR. YIBALA EDIMEK136
Completed
Phase 2
Evaluation of Hyoscine butylbromide effects on pain severity of first stage of labor and fetal heart rate in multiparous womeDelivery.Encounter for full-term uncomplicated deliveryIRCT20180424039407N1Zahedan University of Medical Sciences100
